Works matching IS 08926638 AND DT 2022 AND VI 36 AND IP 12


Results: 44
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    A novel 4′‐brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non‐small‐cell lung cancer without any adverse effects in mice.

    Published in:
    FASEB Journal, 2022, v. 36, n. 12, p. 1, doi. 10.1096/fj.202200669RR
    By:
    • Sabarwal, Akash;
    • van Rooyen, Jaco C.;
    • Caburet, Jeremy;
    • Avgenikos, Moscos;
    • Dheeraj, Arpit;
    • Ali, Mansoor;
    • Mishra, Deepali;
    • de Meester, Joséphine S. B.;
    • Stander, Saskia;
    • van Otterlo, Willem A. L.;
    • Kaschula, Catherine H.;
    • Singh, Rana P.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    Issue Information.

    Published in:
    FASEB Journal, 2022, v. 36, n. 12, p. 1, doi. 10.1096/fsb2.22646
    Publication type:
    Article
    27
    28
    29
    32

    Scientific opportunities in resilience research for cardiovascular health and wellness. Report from a National Heart, Lung, and Blood Institute workshop.

    Published in:
    FASEB Journal, 2022, v. 36, n. 12, p. 1, doi. 10.1096/fj.202201407R
    By:
    • Taylor, Herman A.;
    • Finkel, Toren;
    • Gao, Yunling;
    • Ballinger, Scott W.;
    • Campo, Rebecca;
    • Chen, Rong;
    • Chen, Shu Hui;
    • Davidson, Karina;
    • Iruela‐Arispe, M. Luisa;
    • Jaquish, Cashell;
    • LeBrasseur, Nathan K.;
    • Odden, Michelle C.;
    • Papanicolaou, George J.;
    • Picard, Martin;
    • Srinivas, Pothur;
    • Tjurmina, Olga;
    • Wolz, Michael;
    • Galis, Zorina S.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44